Toll-like receptor 9

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

TLR9

Definition
This section has been translated automatically.

In evolutionary terms, TLRs are old, conserved PRRs (Pattern Recognition Receptors); Toll-like receptors are primarily used for the recognition of so-called "Pathogen Associated Molecular Patterns" (PAMPs). TLRs are transmembrane glycoproteins. Their extracellular, N-terminal domain consists of an LRR that specifically binds different ligands. A transmembrane domain follows. The signal transduction takes place through the cytoplasmic "Toll-interleukin-1 receptor homology" domain, TIR for short. This recruits molecules that also contain a TIR domain, but which may differ from TLR to TLR.

In humans, there are now 10 (TLR-1 to 10) and 12 murine (TLR-1 to 9 + 11 and 13). 6 of the human TLRs bind PAMPs extracellularly (TLR-1, 2, 4, 5, 6, 10) while 4 are only localized intracellularly (TLR-3, 7, 8 and 9).

TLRs are expressed in immune cells of the innate and adaptive immune system (B- and , CD286T cells) as well as in various epithelial cells (e.g. intestinal epithelia, McDermott AJ et al. 2014; Husseinzadeh N et al. 2014). This wide distribution makes TLRs an excellent tool for the innate and acquired immune system. TLRs are thus responsible for the recognition of pathogens and the activation of antigen-specific acquired immunity. Through the activity of TLRs, the innate defence mechanisms (see below immunity, innate) can distinguish between "self" and "foreign". For the detection of pathogens, the TLRs need different adaptor molecules for the activation of intracellular signalling cascades such as: MyD88, TICAM-1 (TRIF), TIRAP/MAL, TRAM, and SARM.

General information
This section has been translated automatically.

The toll-like receptor 9 is bound in intracellular compartments such as the endolysosome. The Toll-like receptor 9 (TLR9) is a cellular DNA receptor of the innate immune system. DNA recognition via TLR9 results in an inflammatory response, which also leads to a Th1-based adaptive immune attack (Sandholm J et al. 2014)

TLR9 mRNA is abundantly expressed in breast cancer. However, the pathophysiological role of TLR9 is not clear, although a high expression of TLR9 tends to be associated with a good prognosis (possible therapeutic consequences?). Furthermore, TLR9 also plays a role in certain forms of CLL (Efremov DG et al. 2013).

Toll-like receptors in particular TLR2, TLR4, and TLR9 are involved in the pathogenesis of inflammatory processes of atherosclerosis. This also applies to coronary arterial disease (CAD). TLR9 stimulates interferon-alphα and increases the cytotoxic activity of CD4+ T cells (Roshan MH et al. 2016).

Various studies have shown that "single nucleotide polymorphisms, so-called SNPs, in the TLR9 gene are associated with an increased risk of tuberculosis in certain populations (Chen Z et al. 2015).

TLR9 recognizes intracellular viral dsDNA. This "pattern recognition" results in the initiation of a specific immune response against HBV. Defects in this immunological defence chain result in a delayed immune response and a protracted HBV infection (Shahrakyvahed A et al. 2014).

Polymorphisms of TLR7 and TLR9 are associated with the development of systemic lupus erythematosus in Asian populations (Lee YH et al. 2012).

Literature
This section has been translated automatically.

  1. Chen Z et al (2015) Association between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis. BMC Pulm Med 15:57.
  2. Efremov DG et al (2013) TLR9 signaling defines distinct prognostic subsets in CLL. Front Biosci (Landmark Ed) 18:371-386.
  3. Lee YH et al.(2012) Associations between TLR
  4. polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clin Exp Rheumatol 30:262-265.
  5. Roshan MH et al(2016) The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis. Int J Inflam 2016:1532832.
  6. Shahrakyvahed A et al.(2014) TLR9: an important molecule in the fight against hepatitis B virus. Postgrad Med J 90:396-401.
  7. Sandholm J et al.(2014) Toll-like receptor 9 in breast cancer. Front Immunol 5:330.

Incoming links (1)

Tlr9;

Outgoing links (1)

Lupus erythematosus systemic;

Authors

Last updated on: 29.10.2020